Vikram Thermo (India) Ltd.
BSE: VIKRAMTH · Commodity Chemicals
Snapshot
Unlock Vikram Thermo (India) Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Vikram Thermo (India) Ltd. specialises in the development, manufacturing, and marketing of pharmaceutical coating polymers and chemical products. The company serves both domestic and international markets with a product portfolio that includes Pharma Polymers and Diphenyl Oxide.
Business Model
The company generates revenue through the production and sale of specialised chemical compounds and pharmaceutical excipients. It operates as a manufacturer and supplier, leveraging its expertise in polymer chemistry to serve the pharmaceutical industry.
Growth Outlook
Growth is primarily driven by the expanding demand for pharmaceutical coating polymers within the global healthcare sector. The company continues to focus on its core chemical manufacturing capabilities to maintain its market position.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks can significantly impact the company's operating margins.
- Regulatory Compliance. The company must adhere to stringent international pharmaceutical quality standards, which may increase operational costs.
- Foreign Exchange Risk. As an exporter, the company is exposed to currency fluctuations that may affect its international revenue realisations.
- Sector Competition. The commodity chemicals sector is highly competitive, potentially pressuring pricing power and market share.
Start your research today
Unlock AI insights, financials, peers and live data on Vikram Thermo (India) Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹135 Cr
TTM · standalone
NET PROFIT
₹38 Cr
TTM · standalone
EPS
₹12.28
TTM · standalone
RETURN ON EQUITY
29.5%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
39.1%
TTM · standalone
P/E
24.3x
Q4 FY26 · standalone
EV/EBITDA
16.8x
Q4 FY26 · standalone
EBITDA MARGIN
41.2%
TTM · standalone
NET PROFIT MARGIN
22.6%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Commodity Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Vikram Thermo (India) Ltd.VIKRAMTH | ₹934 Cr | 24.27 | 16.78 | 7.0% | 41.2% | 29.5% | 39.1% | +80.1% |
Amines & Plasticizers LimitedAMNPLST | ₹951 Cr | 24.66 | 14.85 | -12.4% | 10.8% | 14.0% | 19.2% | -20.9% |
Sree Rayalaseema Hi-Strength Hypo LimitedSRHHYPOLTD | ₹912 Cr | 9.82 | 3.30 | 7.4% | 20.7% | 9.7% | 12.2% | -13.2% |
OCCL LimitedOCCLLTD | ₹819 Cr | 10.94 | 7.00 | 40.2% | 21.3% | 18.1% | 20.8% | +26.7% |
Transpek Industry LimitedTRANSPEK | ₹808 Cr | 17.70 | 6.72 | -4.4% | 19.0% | 6.1% | 7.9% | +3.2% |
Sadhana Nitrochem LimitedSADHNANIQ | ₹806 Cr | -1.17 | -20.08 | -69.0% | -92.0% | -23.1% | -12.5% | -72.6% |
As of Q4 FY26
Financials
Vikram Thermo (India) Ltd.
BSE: VIKRAMTH · Commodity Chemicals
Snapshot
Unlock Vikram Thermo (India) Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Vikram Thermo (India) Ltd. specialises in the development, manufacturing, and marketing of pharmaceutical coating polymers and chemical products. The company serves both domestic and international markets with a product portfolio that includes Pharma Polymers and Diphenyl Oxide.
Business Model
The company generates revenue through the production and sale of specialised chemical compounds and pharmaceutical excipients. It operates as a manufacturer and supplier, leveraging its expertise in polymer chemistry to serve the pharmaceutical industry.
Growth Outlook
Growth is primarily driven by the expanding demand for pharmaceutical coating polymers within the global healthcare sector. The company continues to focus on its core chemical manufacturing capabilities to maintain its market position.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks can significantly impact the company's operating margins.
- Regulatory Compliance. The company must adhere to stringent international pharmaceutical quality standards, which may increase operational costs.
- Foreign Exchange Risk. As an exporter, the company is exposed to currency fluctuations that may affect its international revenue realisations.
- Sector Competition. The commodity chemicals sector is highly competitive, potentially pressuring pricing power and market share.
Start your research today
Unlock AI insights, financials, peers and live data on Vikram Thermo (India) Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹135 Cr
TTM · standalone
NET PROFIT
₹38 Cr
TTM · standalone
EPS
₹12.28
TTM · standalone
RETURN ON EQUITY
29.5%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
39.1%
TTM · standalone
P/E
24.3x
Q4 FY26 · standalone
EV/EBITDA
16.8x
Q4 FY26 · standalone
EBITDA MARGIN
41.2%
TTM · standalone
NET PROFIT MARGIN
22.6%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Commodity Chemicals
As of Q4 FY26